These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 30885163)

  • 1. The prognostic significance of the advanced lung cancer inflammation index in patients with unresectable metastatic colorectal cancer: a retrospective study.
    Shibutani M; Maeda K; Nagahara H; Fukuoka T; Matsutani S; Kimura K; Amano R; Hirakawa K; Ohira M
    BMC Cancer; 2019 Mar; 19(1):241. PubMed ID: 30885163
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prognostic value of advanced lung cancer inflammation index in patients with colorectal cancer liver metastases undergoing surgery.
    Pian G; Hong SY; Oh SY
    Tumori; 2022 Feb; 108(1):56-62. PubMed ID: 33393453
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of Markers of Systemic Inflammation for Predicting Survival and Chemotherapeutic Outcomes and Monitoring Tumor Progression in Patients with Unresectable Metastatic Colorectal Cancer.
    Shibutani M; Maeda K; Nagahara H; Ohtani H; Sakurai K; Yamazoe A; Kimura K; Toyokawa T; Amano R; Kubo N; Tanaka H; Muguruma K; Ohira M; Hirakawa K
    Anticancer Res; 2015 Sep; 35(9):5037-46. PubMed ID: 26254405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
    Song A; Eo W; Lee S
    World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced Lung Cancer Inflammation Index Predicts Outcomes of Patients with Pathological Stage IA Lung Adenocarcinoma Following Surgical Resection.
    Kobayashi S; Karube Y; Inoue T; Araki O; Maeda S; Matsumura Y; Chida M
    Ann Thorac Cardiovasc Surg; 2019 Apr; 25(2):87-94. PubMed ID: 30333361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does advanced lung inflammation index (ALI) have prognostic significance in metastatic non-small cell lung cancer?
    Ozyurek BA; Ozdemirel TS; Ozden SB; Erdoğan Y; Ozmen O; Kaplan B; Kaplan T
    Clin Respir J; 2018 Jun; 12(6):2013-2019. PubMed ID: 29356383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of a novel index of nutrition and inflammation for patients with acute decompensated heart failure.
    Maeda D; Kanzaki Y; Sakane K; Ito T; Sohmiya K; Hoshiga M
    Heart Vessels; 2020 Sep; 35(9):1201-1208. PubMed ID: 32219523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The advanced lung cancer inflammation index is an independent prognostic factor after surgical resection in patients with non-small-cell lung cancer.
    Tomita M; Ayabe T; Nakamura K
    Interact Cardiovasc Thorac Surg; 2018 Feb; 26(2):288-292. PubMed ID: 29049691
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advanced Lung Cancer Inflammation Index, a New Prognostic Score, Predicts Outcome in Patients With Small-Cell Lung Cancer.
    He X; Zhou T; Yang Y; Hong S; Zhan J; Hu Z; Fang W; Qin T; Ma Y; Zhao Y; Cheng Z; Huang Y; Zhao H; Yang G; Zhang L
    Clin Lung Cancer; 2015 Nov; 16(6):e165-71. PubMed ID: 25922292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic value of diffuse cancer inflammation index (ALI), serum neutrophil/lymphocyte (NLR) and platelet/lymphocyte (PLR) in advanced-stage lung cancer.
    Ozturk AE; Komurcuoglu B; Karakurt GK; Ozturk O
    J Cancer Res Ther; 2024 Apr; 20(3):893-897. PubMed ID: 38102903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review.
    Jafri SH; Shi R; Mills G
    BMC Cancer; 2013 Mar; 13():158. PubMed ID: 23530866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of the lymphocyte-to-monocyte ratio in patients with metastatic colorectal cancer.
    Shibutani M; Maeda K; Nagahara H; Ohtani H; Sakurai K; Yamazoe S; Kimura K; Toyokawa T; Amano R; Tanaka H; Muguruma K; Hirakawa K
    World J Gastroenterol; 2015 Sep; 21(34):9966-73. PubMed ID: 26379401
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Predictive Significance of the Advanced Lung Cancer Inflammation Index (ALI) in Patients with Melanoma Treated with Immunotherapy as Second-Line Therapy.
    Cheng X; Dong Y; Lou F
    Cancer Manag Res; 2021; 13():173-180. PubMed ID: 33469361
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The preoperative neutrophil to lymphocyte ratio is a superior indicator of prognosis compared with other inflammatory biomarkers in resectable colorectal cancer.
    Song Y; Yang Y; Gao P; Chen X; Yu D; Xu Y; Zhao J; Wang Z
    BMC Cancer; 2017 Nov; 17(1):744. PubMed ID: 29126400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Significance of Modified Advanced Lung Cancer Inflammation Index (ALI) in Patients with Small Cell Lung Cancer_ Comparison with Original ALI.
    Kim EY; Kim N; Kim YS; Seo JY; Park I; Ahn HK; Jeong YM; Kim JH
    PLoS One; 2016; 11(10):e0164056. PubMed ID: 27706243
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammation-based prognostic scores and nutritional prognostic index in patients with locally-advanced unresectable colorectal cancer.
    Ikeguchi M; Urushibara S; Shimoda R; Yamamoto M; Maeta Y; Ashida K
    World J Surg Oncol; 2014 Jul; 12():210. PubMed ID: 25022764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios predict chemotherapy outcomes and prognosis in patients with colorectal cancer and synchronous liver metastasis.
    Wu Y; Li C; Zhao J; Yang L; Liu F; Zheng H; Wang Z; Xu Y
    World J Surg Oncol; 2016 Nov; 14(1):289. PubMed ID: 27852294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic value of pretreatment inflammatory biomarkers in advanced lung adenocarcinoma patients receiving first-line pemetrexed/platinum doublet.
    Xiong Y; Zhao N; Zheng Y; Wang J; Wei F; Ren X
    Tumour Biol; 2017 Jun; 39(6):1010428317701639. PubMed ID: 28618954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of the advanced lung cancer inflammation index on the outcomes of patients with metastatic colorectal cancer who receive chemotherapy.
    Horino T; Tokunaga R; Miyamoto Y; Hiyoshi Y; Akiyama T; Daitoku N; Sakamoto Y; Yoshida N; Baba H
    Int J Clin Oncol; 2023 Mar; 28(3):400-408. PubMed ID: 36637609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Impact of Neutrophil/Lymphocyte Ratio, Platelet Count, CRP, and Albumin Levels in Metastatic Colorectal Cancer Patients Treated with FOLFIRI-Bevacizumab.
    Artaç M; Uysal M; Karaağaç M; Korkmaz L; Er Z; Güler T; Börüban MC; Bozcuk H
    J Gastrointest Cancer; 2017 Jun; 48(2):176-180. PubMed ID: 27714653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.